Abstract:Ras-related C3 botulinum toxin substrate 2 (RAC2) is a GTPase exclusively expressed in hematopoietic cells that acts as a pivotal regulator of several aspects of cell behavior via various cellular processes. RAC2 undergoes a tightly regulated GTP-binding/GTP-hydrolysis cycle, enabling it to function as a molecular switch. Mutations in RAC2 have been identified in 18 patients with different forms of primary immunodeficiency, ranging from phagocyte defects caused by dominant negative mutations to common variable immunodeficiency resulting from autosomal recessive loss-of-function mutations, or severe combined immunodeficiency due to dominant activating gain-of-function mutations. Here, we describe an 11-year-old girl with combined immunodeficiency presenting with recurrent respiratory infections and bronchiectasis. Immunological investigations revealed low T-cell receptor excision circle/K-deleting recombination excision circles numbers, lymphopenia, and low serum immunoglobulin G. Targeted next-generation sequencing identified a novel heterozygous mutation in RAC2, c.86C > G (p.P29R), located in the highly conserved Switch I domain. The mutation resulted in enhanced reactive oxygen species production, elevated F-actin content, and increased RAC2 protein expression in neutrophils, as well as increased cytokine production and a dysregulated phenotype in T lymphocytes. Furthermore, the dominant activating RAC2 mutation led to accelerated apoptosis with augmented intracellular active caspase 3, impaired actin polarization in lymphocytes and neutrophils, and diminished RAC2 polarization in neutrophils. We present a novel RAC2 gain-of-function mutation with implications for immunodeficiency and linked to functional dysregulation, including abnormal apoptosis and cell polarization arising from altered RAC2 expression. Thus, our findings broaden the spectrum of known RAC2 mutations and their underlying mechanisms.

Short stature and combined immunodeficiency associated with mutations in RGS10

Identification of 11 Potentially Relevant Gene Mutations Involved in Growth Retardation, Intellectual Disability, Joint Contracture, and Hepatopathy

Growth Concerns in Coffin–Lowry Syndrome: A Case Report and Literature Review

KAT6B Genetic Variant Identified in a Short Stature Chinese Infant: A Report of Physical Growth in Clinical Spectrum of KAT6B-Related Disorders

A biallelic mutation in IL6ST encoding the GP130 co-receptor causes immunodeficiency and craniosynostosis

Case Report: Novel Splicing Mutations in RFX5 Causing MHC Class II Deficiency

Combined Immunodeficiency Caused by a Novel De Novo Gain-of-Function RAC2 Mutation

Loss-Of-Function Mutations in the Immunoglobulin Superfamily Member 1 Gene (igsf1) Cause A Novel, X-Linked Syndrome of Central Hypothyroidism and Testicular Enlargement

Heterozygous Recurrent Mutations Inducing Dysfunction of ROR2 Gene in Patients With Short Stature

Combined immunodeficiency caused by a novel homozygous NFKB1 mutation

Loss-of-function Mutations in IGSF1 Cause an X-linked Syndrome of Central Hypothyroidism and Testicular Enlargement.

Novel Combined Immune Deficiency and Radiation Sensitivity Blended Phenotype in an Adult with Biallelic Variations in ZAP70 and RNF168

Perturbations of Genes Essential for Müllerian Duct and Wölffian Duct Development in Mayer-Rokitansky-Küster-Hauser Syndrome.

Genetic studies of 77 cases of short stature with unknown etiology

QSOX2 Deficiency-induced short stature, gastrointestinal dysmotility and immune dysfunction

Immunologic Heterogeneity in 2 Cartilage-Hair Hypoplasia Patients With a Distinct Clinical Course

Variable Syndromic Immunodeficiency in Patients with Biallelic PRIM1 Mutations

Mutations in PRDM15 Are a Novel Cause of Galloway-Mowat Syndrome.

Clinical and functional spectrum of RAC2-related immunodeficiency

A multimorphic mutation in IRF4 causes human autosomal dominant combined immunodeficiency

Molecular diagnosis of patients with syndromic short stature identified by trio whole-exome sequencing